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Abstract
The United States invests more into basic medical research than any other country. This research, mostly done
at medical schools, leads to medical technology patented by private firms through a phenomenon known as
knowledge spillover. In light of this relationship, this thesis will investigate the relationship between the public
investments in the basic medical research sector and the resulting effect on medical patents, contingent on
geographic localization with state-level data. It is hypothesized that the larger the investments awarded to
basic medical research organizations, the greater the number of medical patents within the state. Quantifying
this relationship has important implications for modeling change, economic growth and science policies.
The proposed model relates the number of medical patents per year in a given state, the dependent variable, as
a function of the following independent variables: National Institutes of Health (NIH) funding, National
Science Foundation (NSF) funding, the number of civilian scientists and engineers within the state, and a
state-specific research productivity parameter. The model used is similar to Jaffe (1989) but differs as this
relationship focuses on different independent variables. The data come from a variety of sources including
Jaffe and Trajtenberg (2002), the NIH, and the NSF. These data points will be used to run different regression
analyses to test the relationship in question.
With the regression analysis and time lag adjustments, it is anticipated that the number of patents per year in a
given state will be positively correlated with the number of scientist and engineers and the amount of medical
research funding allotted to each state. The performed regressions support this hypothesis and resulted in
statistically significant coefficients. This relationship will also evaluate the economic aspect of medical
research and determine the effect of knowledge spillover from medical institutions to nearby private inventors.
Ultimately, this may allow for more precise institutional and
geographical allocation of research investments for the purpose of achieving more medical innovations, thus
advancing the field of medicine as a whole.
This article is available in Undergraduate Economic Review: http://digitalcommons.iwu.edu/uer/vol4/iss1/11
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ABSTRACT 
SHAH, JAY H.  Analysis of the Relationship Between Research Grants and Medical 
Patents:  Are the Number of Medical Patents Dependent on NIH and NSF Funding? 
Department of Economics, March 2008. 
 
 
The United States invests more into basic medical research than any other country.  This 
research, mostly done at medical schools, leads to medical technology patented by private 
firms through a phenomenon known as knowledge spillover.  In light of this relationship, 
this thesis will investigate the relationship between the public investments in the basic 
medical research sector and the resulting effect on medical patents, contingent on 
geographic localization with state-level data.  It is hypothesized that the larger the 
investments awarded to basic medical research organizations, the greater the number of 
medical patents within the state.  Quantifying this relationship has important implications 
for modeling change, economic growth and science policies.   
 
The proposed model relates the number of medical patents per year in a given state, the 
dependent variable, as a function of the following independent variables: National 
Institutes of Health (NIH) funding, National Science Foundation (NSF) funding, the 
number of civilian scientists and engineers within the state, and a state-specific research 
productivity parameter.  The model used is similar to Jaffe (1989) but differs as this 
relationship focuses on different independent variables.  The data come from a variety of 
sources including Jaffe and Trajtenberg (2002), the NIH, and the NSF.  These data points 
will be used to run different regression analyses to test the relationship in question. 
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With the regression analysis and time lag adjustments, it is anticipated that the number of 
patents per year in a given state will be positively correlated with the number of scientist 
and engineers and the amount of medical research funding allotted to each state.  The 
performed regressions support this hypothesis and resulted in statistically significant 
coefficients.  This relationship will also evaluate the economic aspect of medical research 
and determine the effect of knowledge spillover from medical institutions to nearby 
private inventors. Ultimately, this may allow for more precise institutional and 
geographical allocation of research investments for the purpose of achieving more 
medical innovations, thus advancing the field of medicine as a whole.   
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CHAPTER 1:  
INTRODUCTION 
A. Basic research vs. Applied research 
Over the course of the past decade, there has been an astonishing increase in the amount 
of capital allocated to basic medical research organizations.  The primary objective of 
basic research is to gain more comprehensive knowledge and understanding of general 
variables, not to create or invent something.  Fundamental research, as it is also known, is 
considered exploratory and mostly driven by the researcher’s or researcher’s 
organizations’ interests and intuition (Moses et al., 2005).   
 
Basic research focuses on scientific principles and discoveries and is considered to be a 
precursor to developments in applied research. Applied research utilizes the discoveries 
of basic research to commercialize applications through patenting.  The research is 
designed to solve practical problems of the modern world.  For example, basic research 
allowed for the discovery of the relationship between electricity and magnetism while 
applied research created the invention of the integrated circuit, the key component in 
microprocessors.  Basic research is typically funded through charitable associations and 
governmental agencies and performed at public institutions.  In contrast, applied research 
is primarily funded through private organizations and conducted at private firms.   
 
B. Knowledge spillover 
 
In reality, however, there is a strong relationship between basic and applied research 
organizations in the form of knowledge spillover.  Knowledge spillover is defined as the 
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transmission of knowledge to others beyond the intended boundaries (Fallah and Ibrahim, 
2004).  Within the past two decades, considerable interest in quantifying the spillover 
effects between the public and private research sectors has attracted more researchers.  
This measurement is important as the amount of knowledge spillover has an immediate 
impact on the firm's innovation efforts.  In addition, firms may decide to free ride on 
other firm's research efforts if large spillovers are present.  When an interviewer stated 
that Siemens, Europe's fifth largest enterprise in terms of employees, conducts little 
research and development, the CEO replied by stating, "We have installed listening posts 
around."  This free riders approach allows firms to benefit from research conducted 
outside their firm.  From an individual firm's perspective, spillovers may create a 
disincentive effect for own research efforts, however large spillovers can increase the 
appropriation possibilities of other firm's knowledge.  Because of these possibilities, 
researchers have focused on measuring the transmitted knowledge between firms (Kaiser, 
2002).   
 
Knowledge spillovers which can be transformed to explicitly stated information such as a 
patent is called 'codified' knowledge (Kaiser, 2002).  Therefore, for codified knowledge 
measurements, most researchers rely heavily on patent and patent citation data to observe 
the effect of geographic localization of knowledge spillover.  Most researchers strongly 
suggest that knowledge spillovers are geographically localized and statistically 
significant.   
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The knowledge spillover effect of medical research has received little attention.  The 
research, whether basic or applied, is conducted to add to the overall knowledge in the 
field of medicine.  Advancements in the medical field are responsible for significant 
benefits, such as vaccines and treatments, which result in increased longevity.  While 
immense amounts of capital are invested into basic medical research, the size of the 
knowledge spillover to the private sector is still unknown.  Estimating this relationship 
will allow for quantifying and further understanding the gains from publicly funded 
medical research. 
 
C. Contribution and hypothesis of this study 
 
In light of the medical research knowledge spillover effect, this thesis will measure the 
relationship between the investments made into the basic medical research sector and the 
resulting effect on medical-based patents, contingent on geographic localization within 
states.  The idea behind this relationship is that public and private medical schools 
receive funding from governmental agencies, such as the National Institutes of Health 
(NIH), and utilize the funding for basic medical research.  Due to knowledge spillovers, 
private firms and inventors use this information to conduct applied research measurable 
by the granting of medical patents.  Observing the link between basic medical research 
and medical patenting allows for measuring the return to public funds spent on medical 
research.  It is hypothesized that the larger the investments awarded to the medical sector, 
the greater the number of medical patents on a state-wide basis.  Observing this 
relationship has important implications for modeling change, economic growth and 
science policies.  It will also allow for more precise institutional and geographical 
7
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allocation of research grants for the purpose of achieving more medical innovations, thus 
advancing the field of medicine as a whole. 
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CHAPTER 2:  
LITERATURE REVIEW 
A. Recent trends in medical research 
 
According to Moses et al. (2005), annual U.S. spending on medical research has doubled 
in the past decade from $37.1 billion in 1994 to more than $94 billion in 2003, an 
increase of 102%.  Dr. Moses and colleagues determined this value by including the 
major sponsors of medical research: federal government, state and local governments, 
private not-for-profit entities including foundations, and the industry itself.  Their 
research found that of the $94 million spent in 2003, 40% came from the public sector 
while 60% was funded privately.  Relative proportions from all public and private 
sources have remained constant.  This parallel growth of public and private spending 
suggests a strong interrelationship between the sources of funds and their use.  The public 
sector consists of federal, state and local funding while the private sector includes private 
not-for-profit companies and industry support (pharmaceutical, biotechnology, and 
medical device firms).  Moses et al. (2005) also report that the total medical research 
expenditures at universities and colleges were $19.6 billion for 2002, up from $10.7 
billion in 1995. The Federal sector accounted for 64% of expenditures while institutional 
funds were responsible for the next largest share at 17%. Institutional funds include 
subsidy from physician practice income, endowments, and hospitals’ support of research. 
 
Moses et al. (2005) reports that of the $94 billion spending for medical research, the 
National Institutes of Health (NIH) and pharmaceutical companies contribute $26.4 
billion, 28% of the total, and $27.0 billion, 29% of the total, respectively.  Biotechnology 
9
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companies contribute $17.9 billion, about 19% of the total spending while medical device 
companies account for $9.2 billion, 10% of the total.  The NIH is the largest federal 
funder of medical research.  In 2005 alone, the NIH spent over $11.5 billion of their $28 
billion budget in NIH awards to medical schools (Cech, 2005).   
 
The medical research industry is divided into three sectors: drug, biotechnology and 
medical device research.  Of these, medical device researchers saw funds rise 264% in 
the past decade.  In contrast, support for pharmaceutical innovations and biotechnology 
firms grew 89% and 98% respectively.  A study done by Reuters (2005) reports that the 
additional dollars spent on medical research has yielded disappointing results with 
regards to pharmaceutical companies.  There has been a significant lag in the 
development of new, useful drugs compared to research results produced by medical 
device and biotechnology industries.        
 
In response to the article by Moses et al. (2005), Woolley and Propst (2005) conducted a 
study and reported on the public mood to such an increase in research spending.  A 
compilation of 70 state surveys and 18 national surveys found that more than half of 
Americans think that the U.S. should spend more on research while two-thirds of all 
Americans are willing to increase taxes to achieve this goal.  A very high proportion of 
Americans (94%) say that medical and health research is important to the US economy, 
and 79% agree that basic science research should be supported by the federal 
government, "even if it brings no immediate benefits."   
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Based on the vast amount of investments reported, the analysis of the relationship 
between grants for basic medical research and the rate of applied research patents is 
necessary to understand the effects of the allocated capital for research purposes.  This 
topic must be further analyzed to gain better understanding of the social rate of return for 
grants given to the basic medical research sector.   
 
B. Flow of university knowledge 
 
Many scholars warn that quantifying the actual flow of knowledge is impossible because 
the flow is invisible and leaves no paper trail that can be measured or tracked (Krugman, 
1991).  A thorough study by Griliches (1990) established quite a strong relationship 
between research and development and the number of patents received at both the cross-
sectional level and the time-series dimension.  Griliches (1990) states that a change in a 
firm’s research and development expenditures are paralleled by changes in patent 
numbers.  As a result of this study, most economists studying this topic utilize patents 
and patent citations to measure innovation.     
   
Beginning with one of the most well-known economists in this area, Adam Jaffe (1993) 
determined that although knowledge spillovers may be invisible, the geographically 
localized effect is quite large and significant.  Jaffe (1989) studied the existence of 
geographically mediated spillovers from university research to commercial innovation, an 
example of movement from basic to applied research.  He used state-level time-series 
data on corporate patents, corporate research and development (R&D), and university 
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research.  Based on his findings, university research directly affected local innovation by 
inducing industrial R&D spending.   
   
Jaffe (1989) stated that there is even more reason, in comparison to other basic research 
organizations, to believe that spillovers exist from universities to firms, since universities 
have less incentive to try to keep research secrets.  He examined the patents granted to 
private companies by state over time and regressed these on industry R&D and university 
research.  He found that the analysis of state-level corporate patent activity provides some 
evidence of the importance of geographically mediated commercial spillovers from 
university research (Jaffe, 1989).   
 
The indirect effect of university research is also important; there appears to be an 
association between industry R&D and university research.  The causality is that 
university research results in an increase in industry R&D and thus, a state that improves 
its university research system will increase local innovation by both attracting industrial 
R&D as well as increasing its productivity (Jaffe, 1989).   
 
C. Clusters and geographic localization 
 
Similar to Jaffe’s (1989) approach on industry research and development, Koo (2005) 
observed geographical patterns of patents in knowledge-based industry clusters.  These 
clusters consist of interconnected businesses within the same geographic areas that bind 
together for the purpose of increased productivity.  The data provide evidence that as 
businesses are closer together, there are increased knowledge spillovers and 
subsequently, increased patenting.  Knowledge-based industry clusters can stimulate 
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inter-firm and inter-industry knowledge spillovers thereby making firms more innovative.  
Examples of such geographic clusters are Silicon Valley in California and the Research 
Triangle in North Carolina.  These areas consist of interrelated businesses.  Silicon 
Valley continues to be the leading high-tech hub because of its large number of engineers 
and venture capitalists, while the Research Triangle Park is home to numerous high-tech 
companies and enterprises with one of the highest concentrations of Ph.Ds per capita 
(U.S. Census, 2000).  
 
Economists have been long arguing that clustering contributes to economic growth.  Even 
before Koo (2005), Grossman and Helpman (1994) centered the theory of endogenous 
economic growth on the idea that accumulation of basic knowledge will eventually find a 
way to productive applications and therefore lead to economic growth.  This perspective 
hints to the premise that location plays a role in knowledge spillovers.  Grossman and 
Helpman (1992) explain that the rate of economic growth could vary across regions due 
to spillovers causing an increase in local knowledge creation as affected by geography.  
Basically, certain regions have higher rates of growth if the clustering is closer together.  
 
Similar to the idea of proximity in clusters by Grossman and Helpman (1992), Keller 
(2002) observes the benefits from spillovers diminish with distance.  Using global data 
that encompasses most of the innovative activity throughout the world, he created a 
model to estimate that technology is to a substantial degree local opposed to global.  He 
estimated that the strength of spillovers is halved at about 1,200 kilometers.  Although 
Keller performed the study internationally, a similar principle applies within just the U.S.  
13
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For some varying distance, dependent on the technology, the benefits of the spillover 
effect are halved.  As the firms get closer within a cluster, more knowledge spillover can 
be expected.  Relating this topic to the paper, the smaller the distance between the 
medical institution and the private institution, the higher the likelihood university 
spillover in the form of patenting will occur.   
 
D. Time and quality effects 
           
A few studies have focused on explicitly introducing time to measure the rate of diffusion 
on the effects of university patenting.  Jaffe and Trajtenberg (1996) developed a model to 
evaluate subsequent patent citations in light of viewing knowledge diffusion.  They 
examined the citation probability ratio by technological field and found the drugs and 
medical field to have the highest lag, on average six years, for predicted citation 
frequency.  Citation probability ratio is the probability that a patent will cite a past patent 
to properly provide reference.  This was greater than all other fields, including chemicals, 
electronics, and mechanical, which were all around four years.  The conjecture to higher 
lag times may be attributed to the long lead times associated with approval from the 
Federal Drug Administration (FDA).  This finding is consistent with most of the research 
done by medical institutions.  Once a patent is granted, for any use of the patent, the drug 
or medical device must go through FDA approval, a process that contains many steps and 
can be very lengthy.  Because of this, the lag in years is greatest for these types of 
patents.  
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The university patenting rate has exploded over the past forty years.  This phenomenon is 
unusual since universities are dedicated to the widespread dissemination of their research 
rather than self-patenting.  Henderson et al. (1998) report that university patents are both 
more important and more general than the average patent although this trend is declining.  
Henderson et al. (1998) show that these two traits of university patents have fallen at the 
same time as the sheer number of university patents have increased.  The decrease in 
importance and generality is largely a result of a very rapid increase in the number of 
low-quality patents.  This increase in the number of patents is attributed to an increased 
rate of technology transfer to the private sector.   
 
While the private sector is filing higher-quality patents, universities are patenting basic, 
low-quality patents for medical usages that have probably increased the social rate of 
return to university research.  According to Henderson et al. (1998), the majority of the 
economic benefits of university research come from inventions in the private sector.  
Regardless, as a result of the increased number of university patents there may be an 
increase in the propensity to patent.  The rate of knowledge transfer from university to 
private sector could also increase (Henderson et al., 1998). 
 
These articles support and provide a solid encompassing background in the relationship 
of the knowledge spillover effect.  While some present a vague relationship between 
universities and patents, none analyze the specific relationship between grants into the 
basic medical research sector and the resulting medical patents from the private sector.   
 
15
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CHAPTER 3: 
 
 THEORETICAL MODEL 
 
A. Rival vs. Excludable goods 
 
The goal of this thesis is to explore the grants made into basic medical research and the 
subsequent spillover into the private sector as an output of medically-related patents.  The 
observation was limited to a state-wide analysis.  Basic scientific research is an example 
of a public good that is both non-rival and non-excludable.  Non-rival goods allow many 
people to consume the same good at the same time without reducing the consumption of 
the others while non-excludable goods are goods that are impossible to prevent people 
who have not paid for it from enjoying its benefits.  Basic research cannot be privately 
provided or traded in competitive markets.  All researchers can take advantage of the 
research at the same time. In contrast, applied research is excludable and non-rivalrous 
(Romer, 1990).  This difference is important in understanding knowledge spillover. It is 
known that basic research is conducted at universities and medical institutions which 
spillover into applied research at private firms and ultimately leads to patenting (Jaffe 
(1989), Henderson et al. (1994)).  In this knowledge spillover relationship between 
medical patents and funding, it is hypothesized that the amount of money allocated to the 
medical research sector through grants has a direct and positive correlation with the 
number of assigned medical patents, on a state-level analysis.   
 
B. Included variables 
 
In lieu of observing the funding into the medical sector, two of the largest sources of 
federal funding were included: National Institutes of Health (NIH) and National Science 
Foundation (NSF) (Moses et al., 2005).  The idea is that the increase in funding from 
16
Undergraduate Economic Review, Vol. 4 [2008], Iss. 1, Art. 11
http://digitalcommons.iwu.edu/uer/vol4/iss1/11
  13 
these sources allows for an increase in the medical research done at the college/university 
receiving the funding.  As more research is performed, there will be more knowledge 
spillover into the private sector that ultimately leads to an increase in medical patents for 
that geographic location.  At the NIH and NSF, funding is allocated to specific 
organizations (colleges, businesses, fellowships) based on submitted proposals.  The 
funding is not general but rather specific.  Therefore, once the funding is received, the 
organization begins working on their proposed plan.     
 
Submitted proposals to the NIH and NSF are typically initiated by qualified scientists and 
engineers and officially submitted by their employing organization.  Including the names 
of the scientists and engineers on the proposal provides it with credibility.  Because of 
this relationship and influence, it is believed that the number of scientists and engineers 
within a certain area have a direct relationship with the rate of medical patenting for that 
area.  Research-based companies are fueled by a large and high-caliber workforce of 
scientists and engineers and are considered to be the key engines of growth (The 
Progressive Policy Institute, 2002). 
 
In an effort to control the state’s previous economic growth and success prior to 1990, a 
variable was included to support the dependent variable of medical patents.  The variable 
consists of all the recorded utility patents from the initial recording year of 1963 through 
1990, for each state.  Using this theoretical background and explained inputs, the 
following data sets were used in estimating the empirical model.   
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CHAPTER 4:  
THE DATA 
To analyze the relationship between medical patents and investments made to the medical 
research sector, data were compiled from a few different sources.  The data for the 
dependent variable, medical patents, were obtained from a book by Jaffe and Trajtenberg 
(2002).  The data included as a compact disc along with the book were originally taken 
from the United States Patent and Trademark Office (USPTO) with certain computations 
added by Jaffe and Trajtenberg.  The data file includes all utility patents from the 
USPTO's TAF computerized database, granted during the period 1963 to December 
1999. Each observation contains classification information reflective of the U.S. Patent 
Classification System as of December 31, 1999.  The database contains approximately 3 
million utility patent observations, each with detailed information on the innovation 
itself, the technological area to which it belongs, the inventors and the organization to 
which the inventors assigned the patent property right.  Of these observations, over 
70,500 patents were identified in the Drugs and Medical category and Surgery & Medical 
Instruments subcategory. For these observations, the inventor’s application state was also 
included.  The data were compiled by application year to obtain the number of medical 
patents per state by year.  In addition to the medical patent observations, a time invariant 
variable represented a base of all patents, by state, from the years 1963-1990.  This state-
level variable, Pat1990, was included as a regressor to proxy for differences in local 
knowledge base and innovativeness across states. 
 
For the 123 medical institutions nationwide, the National Institutes of Health (NIH) 
Awards to Medical Schools based on rank have been obtained from 1990 to 2005 from 
18
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the NIH.  The data were given in both Total Awards (TA) as well as Research Grants 
(RG) for each medical school however the correlation between them was high.  The Total 
Awards value was used in the regressions.  The amounts were then aggregated based on 
state to conform to the rest of the data. 
 
Following the NIH grants, the National Science Foundation (NSF) provided the value of 
awards for each state from 1990 to 2005.  The NSF funds research and education in 
science and engineering through grants, contracts, and cooperative agreements. The 
Foundation accounts for about 20 percent of federal support to academic institutions for 
basic research.   
 
The number of scientists and engineers by state and year were obtained through the 
Division of Science Resources Statistics (SRS) of the National Science Foundation 
(NSF).  This division publishes the Science and Engineering State Profiles.  Although 
these data are compiled biennially, values for the unreported years were estimated as an 
average of the year before and after.   
 
Due to the limiting data set of both the NIH and NSF, the earliest year for observations is 
1990.  The patent data, however, begins in 1963 and ends in 1999.  These limiting data 
sets only allow for complete observations from 1990-1998 for a total of 450 observations 
organized by state and year.  Descriptive statistics for each variable are shown in Table 1 
(appendix). 
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CHAPTER 5:  
 
EMPIRICAL MODEL 
 
A. OLS regression 
 
The OLS model used to estimate the knowledge spillover from investments into the 
medical sector to private patenting was based on the framework initially articulated by 
Zvi Griliches (1979) and implemented by Ariel Pakes and Griliches (1984), Jaffe (1986), 
Jaffe (1989), and others.  It represents the framework of a knowledge production function 
as a modified Cobb-Douglas model with four inputs: 
(1) log(MedPatent)it = β0 + β1log(SE)i(t-l) + β2log(NIH)i(t-l) + β3log(NSF)i(t-l) + β4log(Pat1990)i + εit 
 
where i indexes the unit of observation (states), t is the year year, l is the lag structure, 
MedPatent is the number of utility patents under the Drugs and Medical category and 
Surgery & Medical Instruments subcategory, SE is the number of scientists and 
engineers, NIH and NSF is the amount of grants awarded for each organization 
respectively, and Pat1990 is the base number of patents achieved by state from 1963-
1990.  The ε represents the stochastic error term. 
 
Equation 1 models the governing relationship between medical patents per state and a 
function of scientists and engineers, investments from the NIH and NSF, and a proxy for 
differences in the local knowledge base and innovativeness across states.  The SE 
variable serves as a measure for private resources.  Both the NIH and NSF variables 
measure the total funding, in thousands of dollars, per state.  The inclusion of NSF 
funding also helps to capture the effect of inter/intra-industry spillover.  Lastly, the 
Pat1990 variable serves as a state-specific research productivity parameter.  The natural 
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log of each variable in the equation has been taken which not only accounts for 
diminishing returns but also turns the model into a modified Cobb-Douglas production 
function.  Therefore, each variable’s coefficient is the output elasticity which measures 
the responsiveness of the medical patents to changes in levels of inputs used in the 
production.  The Cobb-Douglas production function also allows for determining constant 
returns to scale.  If all coefficients are summed and they are equal to one, the production 
function has constant returns to scale.  A Wald Test was completed to test constant 
returns to scale. 
 
Once a medical school/university receives funding for a specific project, the research is 
furthered prior to the spillover of knowledge.  The time period prior to spillover can vary 
from a year to three or four, depending on the technology and stage of research.  In 
addition, the nature of patent applications often requires time and effort to establish the 
claims associated with the patent application.  These factors draw attention to the need of 
a proper lag structure.  It is somewhat unreasonable to believe that funding given to a 
medical school will allow for furthering of research to the point that the resulting 
knowledge spillover assists applied research and then translates into a patent application, 
all within one year.  Therefore, Equation 1 contains the variable l to adjust for different 
lag structures.   
 
Jaffe (1989), however, uses a contemporaneous regression, meaning a lag structure was 
not implemented in his equation.  While Jaffe is a well-known and respected researcher 
in this field, his lack of lag within his model is incoherent.  To believe that research in 
universities both spillover and translate into a patent application within the same year 
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may not be unreasonable.  From personal experiences with knowledge spillover, it 
required about a little less than two years to progress from receiving funds for college 
research to produce and submit the application for a medical patent.  Using Equation 1, 
various lag structures may be applied to allow different observations of the knowledge 
spillover effect.  
 
B. Fixed effects specification regression and inclusion of state-specific research 
productivity parameter 
 
As with any economic relationship, there are many independent inputs that affect the 
dependent variable.  Within this relationship possible variables unique to each state 
include but are not limited to: the industry mix (Malerba and Montobbio, 2003), local 
demand, cultural factures and level of urbanization (Audretsch and Lehmann, 2005).  
Because the proposed model cannot include all the possible variables, two approaches 
can be taken.  The first, state fixed-effects model, can be broken down into cross-section 
and period specifications.  With a state fixed-effects model as shown in Equation 2, each 
state has its own intercept.  In practice this means that the coefficients are estimated using 
information about how each variable varies over time.   
(2) log(MedPatent)it = β0i + β1log(SE)i(t-l) + β2log(NIH)i(t-l) + β3log(NSF)i(t-l) + β4log(Pat1990)i + εit 
  
Therefore, no information about the cross-state variation in the variables can be used to 
estimate the coefficient.  The period fixed-effects estimation imposes time independent 
effects for each state and attempts to control for unobserved heterogeneity.  Both cross-
section and period fixed-effects are examined through regressions. 
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The other approach to adjust for unaccounted variables is to include a regressor that is a 
proxy for differences in local knowledge base and innovativeness across states.  Pat1990, 
the sum of all patents from 1963-1990 for each state, is representative of a state-specific 
research productivity parameter.   
 
C. Two-Stage Least Squares (2SLS) regression 
A possible problem with the proposed model is endogeneity, which is when the value of 
one independent variable is dependent on the value of other predictor variables.  
Endogeneity may result in significant correlation between the unobserved variables 
contributing to both the independent and dependent variables.  This can also result in 
biased estimators, incorrect regression coefficients, and correlation with the error term 
(Dowd and Town, 2002). Additionally, the correlation between the dependent variables 
can create significant multicollinearity violating the assumptions of a standard regression 
model.   To correct for this problem, an instrumental variable regression within a two-
stage least squares (2SLS) can replace the standard OLS regression.  The equation for 
this approach is represented in Equation 3.   
(3) log(MedPatent)it = β0 + β1log(SE)i(t-l) + β2log(NIH)i(t-l) + β3log(NSF)i(t-l) + β4log(Pat1990)i + εit 
 
Above each of the possible endogenous variables, which are all of them, bars (or hats) 
above the variables would represent estimated values instead of actual values.  Because 
all the inputs within the equation are possible endogenous variables, an instrument panel 
with all the variables, including different lags, was included.   
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CHAPTER 6:  
 
ESTIMATION RESULTS 
 
A. OLS regressions 
 
As stated above, the regressions were performed with data of 9 years, 1990-1998, for 50-
states.  The panel least squares regressions in Table 2 display the coefficients of the 
independent variables on the dependent variable, logMedPat.  The values in parentheses 
are t-statistics.  As this is a Cobb-Douglas production function, each variable’s coefficient 
is the output elasticity of that input which measures the responsiveness of the dependent 
medical patents as a change in levels of inputs used in the production, ceteris paribus.  
From regression 1 in Table 2, it can be inferred that if the number of scientists and 
engineers doubles within a state, the number of medical patents for that state will increase 
by 76% while doubling NSF and NIH grants causes a 12% and 25% increase 
respectively.  The coefficient for logNSF is significant at the 5% level with logSE and 
logNIH significant at 1%.  The R-squared is 0.774 with a Durbin-Watson statistic of 
0.622.   
 
As discussed above, money invested into the medical research sector in one year may not 
directly result in a patent application in that year.  A lag of one year of all independent 
variables is used in regression 2 of Table 2.  All coefficients are statistically significant at 
the 5% level.  This lag of one year means that the number of scientists and engineers and 
NIH and NSF investments in 1992 are related to the number of medical patent 
applications in 1993.  Two, three and four year lagged regressions with the similar 
coefficients are displayed in Table 2 as regression 3, 4 and 5 respectively.  At the three 
and four year lagged time frames, the coefficient of the NSF variable is not significant 
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past the 10% level.  As the number of lagged years increase, the coefficients fluctuate 
minimally however the R-squared value continually decreases.  Also, each additional lag 
reduces the number of observations by 50.  
 
To check for returns to scale in these regressions, the coefficients of each variable were 
summed.  The total came to 1.2, which represents increasing returns to scale as it is 
greater than one.  To verify, a Wald Coefficient Restrictions Test was performed to 
compute a test statistic based on the unrestricted regression. The Wald statistic measures 
how close the unrestricted estimates come to satisfying the restrictions under the null 
hypothesis. If the restrictions are in fact true, then the unrestricted estimates should come 
close to satisfying the restrictions.  With a coefficient restriction of c(1) + c(2) + c(3) = 
1, the probability of the f-statistic (0.0005) and chi-squared (0.0004) values are both 
significant at the 1% level.  These results mean that there is increasing returns to scales 
and they are significant.  For all other regressions, regression 1 will serve as a reference 
point.      
 
B. Fixed effects specification regressions 
 
Regression 6 in Table 3 estimates a fixed effects model.  Fixed effects specifications, 
either period-fixed or cross-section fixed, is a familiar approach of removing specific 
means from the dependent variable as well as exogenous regressors.  After they are 
removed, the specified regressions are performed on the demeaned data.  Regression 6 
shows that with a period and cross-section fixed effect specification all of the coefficients 
lose significance, along with very different coefficients.  The high R-squared value, 0.961 
can be attributed to the fact that each state received its own intercept while no corss-state 
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variation exists.  To compare one state to another, regressions 7-12 only have fixed 
period effects.  Regression 7 shows 1% significance for the scientists and engineers’ 
variable, the NIH and the NSF.  The coefficients are also similar to those found in 
regression 1.  Regressions 8-12 demonstrate consecutive increases in lag starting with a 
one year lag in regression 8.  As the regressions are lagged, the effect of SE is reduced 
10% by regression 12 (5 year lag) relative to a contemporaneous function.   The 
coefficients for the NSF and NIH variables increase as the years lagged increase.  All 
three variables remain significant at the 1% level throughout the five year lag.  The R-
squared remains around 0.839 throughout these regressions. 
 
C. Research productivity parameter inclusion regressions 
 
Table 4, presents the results from regressions 13-18, all contain various lags in an OLS 
regression model while including the specific research productivity parameter, 
logPat1990.  Regression 13 shows no lag.  The addition of the proxy variable caused the 
coefficient of scientists and engineers to decrease from 0.76 (from regression 1) to 0.33 
however all variable coefficients remain statically significant at the 1% level.  This 
decrease represents a possible correlation between these variables.  The presence of 
scientists and engineers may be representing a previously innovative state.  Scientists and 
engineers may move to a state with a higher level of innovation.  The addition of the 
logPat1990 also caused this regression to represent constant returns to scale.       
 
Regressions 14, 15, 16, and 17 display the results from a 1, 2, 3 and 4 year lag 
respectively.  The one year lag shows a 50% decrease in the coefficient of logPat1990.  
The following year, the value recovers back to 0.321.  The three year lag, regression 16, 
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shows all coefficients to be statistically significant at the 5% level with similar values to 
regression 13.  Regression 17, a lag of 4 years, produces similar coefficients however 
loses the significance of NSF funding at the 10% level.  Regression 18 demonstrates a lag 
of four years with a fixed-period effect specification.  This causes all variables to be 
statistically significant at the 5% level and produces an R-squared of 0.848.  The 
coefficient for NSF grants also exceeds the coefficient for NIH funding. 
 
D. Two-Stage Least Squares regressions 
As mentioned before, these regressions all contain possible endogenous regressors which 
can cause bias OLS coefficients.  For example, the addition of the base logPat1990 
variable caused the coefficient of the scientists and engineers to decrease substantially.  
This could mean that instead of an increase in the number of scientists and engineers 
leading to an increase in medical patents, scientists and engineers could be moving to 
more innovative states because of past success or increased NSF grants.  To adjust for 
these endogenous regressors, a two-stage least squares (2SLS) analysis was performed.  
To correlate endogenous variables, the 2SLS contains an instrument list.  Within the 
regressions, the instrument list consisted of each of the variables included in the model 
with corresponding lags: logSE, logNSF, logNIH, logPat1990.  The two stages refer to 
(1) a stage in which new dependent variables are created to substitute for the original 
ones, and (2) a stage in which the regression is computed in OLS fashion, but using the 
newly estimated variables.   
 
Table 5, regressions 19-24, display the results from two-stage least squares regressions 
with different lagged instrument panels.  Regression 19 of Table 5 shows a regression 
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with a contemporaneous lag including the state-level variable logPat1990 as part of the 
instrument list and as a regressor.  All coefficients remained statistically significant at the 
1 % level with an overall R-squared value of 0.791.  All coefficient values except SE are 
almost identical to those of regression 1.  A significant drop from 0.760 to 0.334 was 
noticed for the SE variable.  A one year lag shown in regression 20 of Table 5 causes the 
scientists and engineering variable to lose overall significance as the coefficient also 
decreases.  This is noticed throughout the two, three and four year lags.  Regressions 21, 
22, and 23 display two, three and four year lags respectively.  The coefficient for NSF 
loses significance at the four year level while the NIH variable and logPat1990 remained 
statistically significant at the 1% level.  The final regression, regression 24, applied a 
fixed period effect to the four year lagged two stage least squares regression.  All three 
variables, except SE are statically significant at the 5% level however the coefficient for 
NSF grants exceeds that of the NIH.   
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CHAPTER 7:   
 
CONCLUSIONS 
 
A. Summary of findings 
 
The analysis of state-level medical patent activity as a function of inputs from the NIH, 
NSF, and the number of scientists and engineers provides evidence of the importance of 
knowledge spillover from the basic to applied sectors of medical research.  Most of the 
regressions demonstrated statistically significant coefficients for the independent 
variables, even after accounting for various lags.  Controlling for the state-specific 
research productivity parameter through 2SLS resulted in a strong correlation between 
the number of medical patents per state and the amount of NIH funding allotted as well as 
the base research productivity parameter.  Controlling for period fixed-effects, 5% 
significance was observed for all independent variables except the scientists and 
engineers and also caused the coefficient for NSF to exceed that of the NIH.  The 
different purpose of NSF and NIH grants initially rejects this finding as the NIH awards 
are specifically for medical school research which leads to more patented medical devices 
while the NSF is in the general field of science.  However, it is possible that awards from 
the NSF require more years to translate into research that can spillover into the applied 
research sector and ultimately lead to medical patents.     
 
In most of the regressions, a low Durbin-Watson (between 0.42 and 0.70) statistic was 
present.  The Durbin-Watson statistic test is used to detect the presence of autocorrelation 
in the residuals from the regression analysis.  A value around two indicates that there 
appears to be no autocorrelation. If the Durbin-Watson statistic is substantially less than 
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2, there is evidence of positive serial correlation within the error term which may cause 
biased coefficients.  A future study should address the possible serial correlation. 
 
These regression analyses approached from OLS, fixed-effects, and two-stage least 
squares methods, mostly concluded consistent and statistically significant results that 
yielded similar coefficients for the NIH and NSF variables.  On average, if the amount of 
NIH and NSF funding were to double, the number of medical patents per state would 
increase by around 13% and 25% respectively.  On average, before logPat1990 was 
included, doubling the number of scientists and engineers per state would cause roughly a 
70% increase in medical patents.  Once the specific research productivity parameter 
logPat1990 was included, the SE term dropped to around 30% indicating possible 
correlation.  This evidence supports the proposed hypothesis.     
 
B. Policy Implications 
 
Understanding this relationship is important for future policy implications commonly 
drawn from new growth theory.  It states that as a result of convexities in knowledge 
production and the resultant increasing returns, knowledge resources, such as research 
and development should be publicly supported.  These spillovers may also serve as a 
focus for enhancing public policy to continue economic growth and development 
(Audretsch and Feldman, 2003).   
 
Loscalzo (2006) states that we have recently entered another period of stagnant funding 
for the NIH.  Having doubled between 1998 and 2003, the NIH budget is expected to be 
$28.6 billion for fiscal year 2007, a 3.8 percent decrease which is the first budgeted 
reduction in NIH support since 1970.  This downturn is more severe than any previously 
30
Undergraduate Economic Review, Vol. 4 [2008], Iss. 1, Art. 11
http://digitalcommons.iwu.edu/uer/vol4/iss1/11
  27 
faced and threatens to erode the benefits of previous investments.  It takes many years for 
institutions to develop scientists and engineers skilled in modern research techniques and 
to build the costly, complicated infrastructure necessary for medical research.  Loscalzo 
(2006) goes on to state that the situation is unlikely to improve anytime soon as the 
resources required by the war and erosion of the tax base by the current administration's 
fiscal policies are expected to have long-term, far-reaching effects.  
 
Studies observing the benefits of NIH funding, such as this thesis, can show the positive 
effects of NIH funding in not only basic research but also show that the research actually 
translates into significant medical patents within the applied research sector.  If enough 
studies are produced with significant results, the NIH could provide substantial evidence 
to the government to hopefully increase funding to continue medical research.    
 
C. Suggestions for Future Research 
 
Based on the low Durbin-Watson statistic, future research should focus on increasing this 
value by controlling for serial correlation.  To adjust for serial correlation, more inputs 
could be included in the regressions to account for possible variables unique to each state.  
In addition, a larger data set including more recent data could provide more information 
about the relationship between medical patents and public funding over time. 
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